Overview
|
The 2nd Annual Biofluid Biopsies and High Value Diagnostics 2015 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.
|
|
The Biofluid Biopsies Conference Track focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
The High-Value Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.
We also explore the front-end sample preparation challenges and approaches for the deployment of various biofluid classes (
plasma, serum, urine, cerebrospinal fluid, ovarian follicular fluid, and saliva) into diagnostics development in both the conference tracks.
All conference delegates receive access to both concurrent, co-located conference tracks enabling maximal learning and maximizing networking opportunities. The two tracks are intertwined and presentations from the two tracks
en bloc provide a complete picture of the liquid biopsy space as it currently exists.
Present Your Research at this Conference in a Poster to a Worldwide Audience. Poster Submission Deadline: November 2, 2015.
Liquid Biopsy Slide Deck
.png)
